Tampering with Prescription Opioids: Nature and Extent of the Problem, Health Consequences, and Solutions-Reference-Cited by-同舟云学术

Tampering with Prescription Opioids: Nature and Extent of the Problem, Health Consequences, and Solutions

Published:2011-04-26 Issue:4 Volume:37 Page:205-217
ISSN:0095-2990
Container-title:The American Journal of Drug and Alcohol Abuse
language:en
Short-container-title:The American Journal of Drug and Alcohol Abuse

Author:

Katz Nathaniel¹²,Dart Richard C.³,Bailey Elise³,Trudeau Jeremiah¹,Osgood Eric¹,Paillard Florence⁴

Affiliation:

1. Analgesic Solutions, Natick, MA, USA

2. Tufts University School of Medicine, Boston, MA, USA

3. Rocky Mountain Poison & Drug Center, Denver Health, Denver, CO, USA

4. FocusBiocom, Durango, CO, USA

Publisher

Informa UK Limited

Subject

Psychiatry and Mental health,Clinical Psychology,Medicine (miscellaneous)

Link

https://www.tandfonline.com/doi/pdf/10.3109/00952990.2011.569623

Reference40 articles.

1. Pharmacokinetic considerations in abuse liability evaluation

2. Ephemeral profiles of prescription drug and formulation tampering: Evolving pseudoscience on the Internet

3. Development and Preliminary Experience with an Ease of Extractability Rating System for Prescription Opioids

4. Challenges in the Development of Prescription Opioid Abuse-deterrent Formulations

5. Savage S, Covington EC, Heit HA, Hunt J, Joranson D, Schnoll SH. Definitions related to the use of opioids for the treatment of pain. A consensus document from the American Academy of Pain Medicine, the American Pain Society, and the American Society of Addiction Medicine, 2001. Available at: http://www.ampainsoc.org/advocacy/opioids2.htm. Last accessed on September 12, 2008.

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review on Recent Development in Opioid Abuse-Deterrent Formulation Technologies and Regulatory Expectation;Biomedical and Pharmacology Journal;2024-06-25

2. Opioid Prescribing by Emergency Physicians: Trends Study of Medicare Part D Prescriber Data 2013-2019;The Journal of Emergency Medicine;2023-10

3. A Cross-Sectional Study of Tampering in Xtampza ER, an Abuse-Deterrent Formulation of an Extended-Release Opioid, in a Treatment Center Population;Clinical Drug Investigation;2023-03

4. Intranasal Use of Prescription Stimulants Among Adults Aged 18 to 30: Results From A Crowdsourcing Platform;Journal of Attention Disorders;2022-07-29

5. Are Any Changes in Carotid Intima–Media Thickness Associated with Cardiometabolic Risk Among Adult Bantu Central African Hypertensive Patients from Monkole and Biamba Marie Mutombo Hospitals?;Vascular Health and Risk Management;2022-07